Exercise and Dietary Change after Diagnosis and Cancer-related Symptoms in Long-term Survivors of Breast Cancer: CALGB 79804 Alfano, Catherine M. , Day, Jeannette M. , Katz, Mira L. ... - - Psychooncology - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70804
The Complementary Nature of Patient-Reported Outcomes (PROs) and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591) Atherton, Pamela J. , Watkins-Bruner, Deborah W. , Gotay, Carolyn ... - - J Pain Symptom Manage - 2015 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0591
Patient Reported Outcomes Questionnaire Compliance in Cancer Cooperative Group Trials (Alliance N0992) Atherton, Pamela J , Burger, Kelli N , Pederson, Levi D ... - - Clin Trials - 2016 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0992
Measurement of Affective and Activity Pain Interference Using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903 Atkinson, Thomas M. , Halabi, Susan , Bennett, Antonia V. ... - - Pain Med - 2012 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70903
Comparison Between Clinician- and Patient-Reporting of Baseline (BL) and Post-BL Symptomatic Toxicities in Cancer Cooperative Group Clinical Trials (NCCTG N0591 [Alliance]) Atkinson, Thomas M. , Satele, Daniel V. , Sloan, Jeff A. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N0591
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048 Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N1048
Evaluation of mode equivalence of the MSKCC Bowel Function Instrument, LASA Quality of Life, and Subjective Significance Questionnaire items administered by Web, interactive voice response system (IVRS), and paper Bennett, Antonia V. , Keenoy, Kathleen , Shouery, Marwan ... - - Qual Life Res - 2016 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - NCT01458509
Perioperative Patient Reported Outcomes Predict Serious Postoperative Complications: A Secondary Analysis of the COST Trial Bingener, Juliane , Sloan, Jeff A. , Novotny, Paul J. ... - - J. Gastrointest. Surg. - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-93-46-53
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1 Brown, L. C. , Atherton, P. J. , Neben-Wittich, M. A. , Wender, D. B. ... - - Support Care Cancer - 2013 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - N09C1
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology Cerhan, Jane H , Anderson, S Keith , Butts, Alissa M , Porter, Alyx B ... - - Neurooncol Pract - 2019 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0577 , A221101 , N0874 , N107C
Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392) Chauhan, C. , Atherton, P. J. , Satele, D. , Dueck, A. C. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - NCCTG-N0392
Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803) Cohen, Harvey Jay , Lan, Lan , Archer, Laura ... - - J Geriatr Oncol - 2012 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - C70103 , CALGB-70803
Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Deshields, Teresa L , Dueck, Amylou C , Rogers, Kerry ... - - Leuk. Lymphoma - 2019 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-10501 , CALGB-70603
Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials Dressler, L. G. , Deal, A. M. , Watson, D. , Hollis, D. , Owzar, K. ... - - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Dueck, A. C. , Mendoza, T. R. , Mitchell, S. A. , Reeve, B. B. ... - - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - Comprehensive
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance) Dueck, A. C. , Singh, J. , Atherton, P. , Liu, H. , Novotny, P. ... - - Osteoporos Int - 2015 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N02C1 , N03CC
Calibrating clinically significant effects in survival and response endpoints in cancer clinical trials. Dueck, A. , Sargent, D. , Novotny, P. , Decker, P. , Nelson, H. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - N0591
Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Dueck, Amylou C. , Mendoza, Tito R. , Mitchell, Sandra A. ... - - JAMA Oncol - 2015 Manuscript - No-Endpoint Endpoint - Primary Analysis - Health Outcome - Comprehensive
Analysis of longitudinal quality of life data in high-risk operable patients with lung cancer: Results from ACOSOG Z4032 (Alliance) a multicenter randomized trial Fernando, Hiran C , Landreneau, Rodney J , Mandrekar, Sumithra J ... - - J. Thorac. Cardiovasc. Surg. - 2015 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - ACOSOG-Z4032
Factors contributing to cancer screening in African Americans Ferrans, C. E. , Ryan, C. , Archer, L. E. , Freels, S. , Lan, L. ... - - J. Clin. Oncol. - 2008 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-119901
Predictors of accrual success for cooperative group trials: The Cancer and Leukemia Group B (Alliance) experience Gordon, David , Liu, Qianying , Kleinman, Benjamin ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - Comprehensive
Real-Time Fatigue and Free-Living Physical Activity in Hematopoietic Stem Cell Transplantation Cancer Survivors and Healthy Controls: A Preliminary Examination of the Temporal, Dynamic Relationship Hacker, Eileen Danaher , Kim, Inah , Park, Chang ... - - Cancer Nurs - 2017 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
Assessing the clinical significance of real-time Quality of Life (QOL) data in cancer patients treated with radiation therapy Halyard, M. Y. , Tan, A. D. , Callister, M. D. , Ashman, J. B. ... - ASCO - J. Clin. Oncol. - 2010 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-89-20-52
Patient Education Level As a Predictor of Survival In Lung Cancer Clinical Trials Herndon, James E. , Kornblith, Alice B. , Holland, Jimmie C. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70601
Can a Gastric Cancer Risk Survey Identify High-Risk Patients for Endoscopic Screening? A Pilot Study In, Haejin , Langdon-Embry, Marisa , Gordon, Lauren ... - - J. Surg. Res. - 2018 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907 Kornblith, Alice B. , Lan, Lan , Archer, Laura , Partridge, Ann ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - C70103 , CALGB-49907
Increasing Adherence to Adjuvant Hormone Therapy among Breast Cancer Patients: A Smart Phone App-Based Pilot Study Krok-Schoen, Jessica L. , Naughton, Michelle J. , Young, Gregory S. ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens Lamont, E. B. ... - - Med Care - 2014 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - CALGB-9344 , CALGB-9730 , CALGB-9235 , CALGB-9732 , CALGB-80203 , CALGB-89803
Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants Lamont, Elizabeth B. , Herndon, James E. , Weeks, Jane C. ... - - Med Care - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-70101
Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802) Lamont, Elizabeth B. , Yu, Menggang , He, Yulei , Saltz, Leonard ... - - J Geriatr Oncol - 2014 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70802
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck Amylou , Chauhan, Cynthia ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Association Between Patient Perception of Oncology Clinical Trial Participation and Survival: NCCTG N0392 (Alliance) Le-Rademacher, Jennifer , Dueck, Amylou , Chauhan, Cynthia ... - MASCC / ISOO - - 2016 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N0392
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients Liu, Heshan , Tan, Angelina D. , Qin, Rui , Sargent, Daniel J. ... - - SOJ Anesthesiol Pain Manag - 2015 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N0897
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 Loprinzi, C. L. , Reeves, B. N. , Dakhil, S. R. , Sloan, J. A. ... - - J. Clin. Oncol. - 2011 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - N08C1
Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance) Major-Elechi, Brittny T. , Novotny, Paul J. , Singh, Jasvinder A. ... - - Int J Stat Med Res - 2018 Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - NCCTG-89-20-52
How Much Missing Data is Too Much? Monte Carlo Simulations to Develop SISAQOL Guidelines for Missing Data Handling. Mazza, Gina L. , Coens, Corneel , Pe, Madeline , Dorme, Lien ... - ISOQOL - Qual Life Res - 2018 Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -
Quality of life (QOL) and toxicity among patients in CALGB 80405 Naughton, M. J. , Schrag, D. , Venook, A. P. , Niedzwiecki, D. ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - C80405
Health-related quality of life outcomes for the LEAP Study - Alliance 70305: a lymphedema prevention intervention trial for newly-diagnosed breast cancer patients Naughton, MJ , Seisler, DK , Sloan, JA , Liu, H , Le-Rademacher, J ... - ISOQOL - Qual Life Res - 2018 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70305
Electronic Patient-Reported Outcomes and Toxicities During Radiotherapy for Head and Neck Cancer Niska, Joshua R. , Halyard, Michele Y. , Tan, Angelina D. ... - - Qual Life Res - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-892052
Arm swelling and psychological well-being among long-term breast cancer survivors Oliveri, J. M. , Day, J. , Alfano, C. M. , Herndon, J. E. 2nd ... - APHA - American Public Health Association Annual Meeting - 2007 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-79804
Arm/Hand Swelling and Perceived Functioning among Breast Cancer Survivors 12 Years Post-diagnosis: CALGB 79804 Oliveri, Jill M. , Day, Jeannette M. , Alfano, Catherine M. ... - - J Cancer Surviv - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-79804
Applying a Conceptual Model for Examining Health-Related Quality of Life in Long-Term Breast Cancer Survivors: CALGB Study 79804 Paskett, Electra D. , Herndon, James E. , Day, Jeannette M. ... - - Psychooncology - 2008 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - C8541 , CALGB-79804
Health-Related Quality of Life in Long-Term Breast Cancer Survivors: Differences by Adjuvant Chemotherapy Dose in CALGB Study 8541 Paskett, Electra , Herndon, James , Donohue, Kathleen ... - - Cancer - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - C8541 , CALGB-79804
Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative Pe , M. , L., Dorme , C., Coens , E., Basch , Melanie, Calvert ... - ISOQOL - Qual Life Res - 2018 Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -
Quality of Life Analysis of N0877 (Alliance): Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM) Qin, Rui , Tan, Angelina D. , Sloan, Jeff A. , Johnson, Derek Richard ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N0877
Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1 Reeves, B. , Dakhil, S. R. , Sloan, J. A. , Kamal, A. , Wolf, S. L. ... - - J. Clin. Oncol. - 2010 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - N08C1
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Romanus, Dorothy , Kindler, Hedy L , Archer, Laura , Basch, Ethan ... - - J Pain Symptom Manage - 2012 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-80303
Adherence, persistence and toxicity with oral CMF in older women with early stage breast cancer in CALGB 49907 (adherence companion study 60104) Ruddy, K. , Archer, L. E. , Cohen, H. J. , Winer, E. P. , Hudis, C. A. ... - - Cancer Res. - 2010 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - C60104
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601 SMITH, E.M.L. , PANG, H. , YE, C. , CIRRINCIONE, C. , FLEISHMAN, S. ... - - Eur J Cancer Care (Engl) - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-170601
A patterns-of-care study of post-progression treatment (Rx) among patients (pts) with advanced pancreas cancer (APC) after gemcitabine therapy on Cancer and Leukemia Group B (CALGB) study 80303 Schrag, D. , Archer, L. E. , Wang, X. , Romanus, D. , Mulcahy, M. ... - - J. Clin. Oncol. - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - CALGB-80303
Clinical trial participants' strategies for coping with prescription drug costs: A companion study to CALGB 80405 Schrag, D. , Naughton, M. J. , Kesselheim, A. , Archer, L. E. ... - ASCO - J. Clin. Oncol. - 2009 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - C80405
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405. Schrag, Deborah , Dueck, Amylou C. , Naughton, Michelle Joy ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-80405 , CALGB-70502
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales. Singh, Jasvinder A , Locke, Dona E , Satele, Daniel ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - 954651 , NCCTG-95-20-53 , NCCTG-95-24-52 , 959204 , NCCTG-964251 , 979202 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-98-72-52 , NCCTG-959257 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales Singh, Jasvinder A , Satele, Daniel , Pattabasavaiah, Suneetha ... - - Health Qual Life Outcomes - 2014 Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-95-20-53 , 954651 , 959204 , NCCTG-95-24-52 , NCCTG-964251 , 979202 , NCCTG-97-24-51 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-959257 , NCCTG-98-72-52 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253
Expansion of the Wilson & Cleary Theoretical Model to Incorporate Genetic Influences on Quality of Life Sloan J ... - ISOQOL - - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - NCCTG-N9741
A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. Sloan, J. A. , Liu, H. , Sargent, D. J. , Satele, D. , Schaefer, P. L. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - Comprehensive
Was it worth it (WIWI)? patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) Phase III Trial N0147 Sloan, J. A. , Mahoney, M. R. , Sargent, D. J. , Hubbard, J. M. ... - ASCO - J. Clin. Oncol. - 2011 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - NCCTG-N0147
Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147). Sloan, J. A. , Shi, Q. , Lee, A. , Diasio, R. B. , Pavey, E. S. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - NCCTG-N0147
Lessons from Large Scale Collection of Patient Reported Outcomes: Implications for Big Data Aggregation and Analytics Sloan, Jeff A. , Halyard, Michele , El Naqa, Issam ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - N9741 , NCCTG-89-20-52
Prognostic significance of baseline fatigue for overall survival: A patient-level meta-analysis of 43 oncology clinical trials with 3915 patients Sloan, Jeff A. , Liu, H. , Satele, D.V. , Puttabasavaiah, S. ... - - Trends Cancer Res - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N0591
Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials Sloan, Jeff A. , Sargent, Daniel J. , Novotny, Paul J. ... - - J Pain Symptom Manage - 2014 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - NCCTG-89-20-52
Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states Sprangers, Mirjam A. G. , Bartels, Meike , Veenhoven, Ruut ... - - Qual Life Res - 2010 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N9741
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes Sprangers, Mirjam A. G. , Sloan, Jeff A. , Barsevick, Andrea ... - - Qual Life Res - 2010 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Health Outcome - N9741
A Survey of Survivors Stark, Nancy - - Appl Clin Trials - 2007 Manuscript - Primary Endpoint - Primary Analysis - Health Outcome - Comprehensive
A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance) Thanarajasingam, Gita , Atherton, Pamela J. , Novotny, Paul J. ... - - Lancet Oncol. - 2016 Manuscript - Primary Endpoint - Comprehensive Analysis - Health Outcome - N9741 , NCCTG-97-92-54
Beyond maximum grade: A novel, longitudinal toxicity over time (ToxT) adverse event analysis of lenalidomide in follicular lymphoma in Alliance A151617 Thanarajasingam, Gita , Dueck, Amylou , Novotny, Paul J. ... - ICML - Hematol Oncol - 2017 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - CALGB-50401 , A151617
Economic analysis of the Clinical Outcomes of Surgical Therapy (COST) trial comparing laparoscopically-assisted colectomy (LAC) with open colectomy (OC) for colon cancer. Weeks, J. , Nelson, H. , Romanus, D. , Long, K. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - INT-0146 , NCCTG-93-46-55 , CALGB-9396
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA Wolf, S. L. , Barton, D. L. , Qin, R. , Wos, E. J. , Sloan, J. A. ... - - Support Care Cancer - 2012 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - N06CA
Relationship of sensory symptoms and motor function in patients with chemotherapy-induced peripheral neuropathy (CIPN) utilizing the EORTC QLQ CIPN20: NCCTG study N06CA Wolf, S. L. , Qin, R. , Barton, D. L. , Sloan, J. A. , Liu, H. ... - - J. Clin. Oncol. - 2009 Abstract - Secondary Endpoint - Primary Analysis - Health Outcome - N06CA
